Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ:TEM) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. On March 3, the institution announced a strategical concern with Merck to fast-track the improvement of AI-driven precision medicine and enactment the pharma-maker’s oncology portfolio and different therapeutic offerings.

As portion of the agreement, Merck volition leverage Tempus AI, Inc. (NASDAQ:TEM)’s de-identified information and Lens Platform and Workspaces technologies to make caller discoveries and accelerate the improvement and effectual usage of campaigner therapies connected a ample scale.

In different news, connected February 25, JPMorgan expert Casey Woodring slashed the stock’s terms people to $60 from $80, with a Neutral rating, pursuing the company’s Q4 net telephone a time prior.

Photo from Iovance Biotherapeutics website

According to TipRanks, the steadfast cited Tempus AI, Inc.’s (NASDAQ:TEM) ‘clouded visibility’ connected information upside and a revision to its outlook for Ambry arsenic the crushed down the adjustment.

As of the adjacent of concern connected March 4, the banal is simply a Moderate Buy, with an mean upside imaginable of 52.5%.

Tempus AI, Inc. (NASDAQ:TEM) is simply a healthcare exertion institution that uses artificial quality to beforehand precision medicine.

While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 10 Best Magic Formula Stocks for 2026.

Disclosure: None. Follow Insider Monkey connected Google News.